Assessment of national strategies for control of high-pathogenicity avian influenza and low-pathogenicity notifiable avian influenza in poultry, with emphasis on vaccines and vaccination.
about
The emergence and diversification of panzootic H5N1 influenza virusesGlobal epidemiology of avian influenza A H5N1 virus infection in humans, 1997-2015: a systematic review of individual case data.Efficient strategy for constructing duck enteritis virus-based live attenuated vaccine against homologous and heterologous H5N1 avian influenza virus and duck enteritis virus infection.Assessment of China's H5N1 routine vaccination strategyCharacterization of Clade 7.2 H5 Avian Influenza Viruses That Continue To Circulate in Chickens in ChinaAvian influenza in Latin America: A systematic review of serological and molecular studies from 2000-2015.Immunogenicity and efficacy of fowlpox-vectored and inactivated avian influenza vaccines alone or in a prime-boost schedule in chickens with maternal antibodies.Variation in protection of four divergent avian influenza virus vaccine seed strains against eight clade 2.2.1 and 2.2.1.1. Egyptian H5N1 high pathogenicity variants in poultry.Chimeric newcastle disease virus protects chickens against avian influenza in the presence of maternally derived NDV immunityImmune escape mutants of Highly Pathogenic Avian Influenza H5N1 selected using polyclonal sera: identification of key amino acids in the HA proteinAntibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia.Dryocrassin ABBA, a novel active substance for use against amantadine-resistant H5N1 avian influenza virusEffect of passive immunization on immunogenicity and protective efficacy of vaccination against a Mexican low-pathogenic avian H5N2 influenza virus.Immunopotentiators Improve the Efficacy of Oil-Emulsion-Inactivated Avian Influenza Vaccine in Chickens, Ducks and Geese.Previous infection with virulent strains of Newcastle disease virus reduces highly pathogenic avian influenza virus replication, disease, and mortality in chickensInsight into alternative approaches for control of avian influenza in poultry, with emphasis on highly pathogenic H5N1Role of vaccination-induced immunity and antigenic distance in the transmission dynamics of highly pathogenic avian influenza H5N1Genetic and antigenic analysis of H5N1 viruses for selection of HA-donor virus for vaccine strains.Continual Antigenic Diversification in China Leads to Global Antigenic Complexity of Avian Influenza H5N1 Viruses.FLOCK-BASED SURVEILLANCE FOR LOW PATHOGENIC AVIAN INFLUENZA VIRUS IN COMMERCIAL BREEDERS AND LAYERS, SOUTHWEST NIGERIA.Intervention strategies to reduce the risk of zoonotic infection with avian influenza viruses: scientific basis, challenges and knowledge gaps.Optimized clade 2.3.2.1c H5N1 recombinant-vaccine strains against highly pathogenic avian influenza.Animal influenza research needs: protecting humans, animals, food, and economies.Single Dose of Consensus Hemagglutinin-Based Virus-Like Particles Vaccine Protects Chickens against Divergent H5 Subtype Influenza Viruses.Field effectiveness of highly pathogenic avian influenza H5N1 vaccination in commercial layers in Indonesia.Challenges of influenza A viruses in humans and animals and current animal vaccines as an effective control measure.Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture.Challenge for One Health: Co-Circulation of Zoonotic H5N1 and H9N2 Avian Influenza Viruses in Egypt.Influenza Viral Vectors Expressing Two Kinds of HA Proteins as Bivalent Vaccine Against Highly Pathogenic Avian Influenza Viruses of Clade 2.3.4.4 H5 and H7N9.Potential mediators of in ovo delivered double stranded (ds) RNA-induced innate response against low pathogenic avian influenza virus infection.Influenza viral vectors expressing two kinds of HA proteins for bivalent vaccines against clade 2.3.4.4 and clade 2.3.2.1 H5 HPAIVs.
P2860
Q28292060-9FDD5044-47DE-4908-A7E1-B1131554EF45Q30250234-C9913726-783F-430D-9D9D-13C84AA57AADQ30373912-6B5453D1-77A5-4FE3-A5B2-9FE327FC7897Q30377554-D24F4C6C-A3CA-4B78-A152-E0F8BD5C033EQ30392194-C37B0E11-6078-4A07-9751-12ACA9EA0524Q33817436-8B98CA8B-E07D-4F3D-9982-016ECFFCD001Q34643285-E6054F7E-3DD1-46AB-9F7C-5D92816D4AADQ34671720-CEBAD6A7-884D-46DB-94C6-80143325E9B3Q34983940-BEE91183-2F07-429E-91FC-33CA6430F567Q35105831-19590A57-345C-4A9D-BC7E-98C807FFA129Q35488007-507A12D4-47A7-41B5-B16F-8FC5EA70397DQ35746512-6C2762D3-EBB1-479B-98AD-4A55FA916F8BQ35830963-68C3F399-592B-4715-8783-85A91A1F823DQ36032289-498B675B-D5B3-4904-9155-DA6B17BEF8ACQ36084974-C6E34DD0-7D4C-4CEC-B1B1-F51FAEF09362Q36432764-A4C22209-1DFF-4D15-84C7-5F2468DF5354Q36596186-178235A2-45C2-4F56-AC35-24946B507CFFQ37321514-0308CD68-04DF-4476-99D6-CE9931258E14Q37681699-27A39F62-60E9-4E11-AF3D-D5117E157571Q37698994-359A10C7-0EAE-44F3-A034-E77A3674DFF0Q38137378-EC6E3860-8E5C-4667-A0FE-086DEE206898Q40062827-57B2311E-17D3-4D4B-9129-E9194C326958Q45278338-487B046E-CD74-48DE-BBC5-9D9D738EB02DQ47157586-3EEB773A-1AFA-4F0B-B50C-F6B463CEC5F5Q47556025-ADB1C324-705D-4A3F-92E5-D88EF3590A60Q48109162-926A87F2-7424-4948-8F61-3D2BE7568E28Q50308620-DCDEF2E8-8C7F-4316-BD8F-D3BF36ECCC99Q52664438-BCBA8D2D-4421-426F-A3E7-E31CF2460E5DQ53829188-A21B672B-969A-450A-B914-EE3FB8142865Q54257709-54D3C2B3-9948-4A1B-9BCC-97606BFE5B32Q55311602-B8BC72F8-95A4-4865-A1A3-CF64D25FC2C1
P2860
Assessment of national strategies for control of high-pathogenicity avian influenza and low-pathogenicity notifiable avian influenza in poultry, with emphasis on vaccines and vaccination.
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Assessment of national strateg ...... s on vaccines and vaccination.
@ast
Assessment of national strateg ...... s on vaccines and vaccination.
@en
Assessment of national strateg ...... s on vaccines and vaccination.
@nl
type
label
Assessment of national strateg ...... s on vaccines and vaccination.
@ast
Assessment of national strateg ...... s on vaccines and vaccination.
@en
Assessment of national strateg ...... s on vaccines and vaccination.
@nl
prefLabel
Assessment of national strateg ...... s on vaccines and vaccination.
@ast
Assessment of national strateg ...... s on vaccines and vaccination.
@en
Assessment of national strateg ...... s on vaccines and vaccination.
@nl
P2093
P356
P1476
Assessment of national strateg ...... is on vaccines and vaccination
@en
P2093
K Hamilton
K Miyagishima
P304
P356
10.20506/RST.30.3.2081
P50
P577
2011-12-01T00:00:00Z